Riyadh, Riyadh Global Medical Biotechnology Summit (RGMBS) 2021 concluded its scientific sessions today.
The three-day summit witnessed a number of sessions, enriched by more than 50 specialized speakers and researchers, locally and globally, and received more than 112,000 registrants from 164 countries around the world, as well as dealing with important topics about medical technology and its challenges.
The outcomes of the summit resulted in the signing of 6 important memoranda of understanding, which brought together King Abdullah International Medical Research Center (KAIMRC) in the Health Affairs of the Ministry of National Guard; Ministry of Health; Ministry of Investment; Ministry of Industry and Mineral Resources, and Saudi Data and Artificial Intelligence Authority (SDAIA),with specialized scientific companies such as Pfizer, AstraZeneca, Citiva, Ebzem and Rockland.
It is worth mentioning that RGMBS 2021 was virtually organized by KAIMRC at the Ministry of National Guard's Health Affairs in cooperation with King Saud bin Abdulaziz University for Health Sciences.
Source: Saudi Press Agency